Literature DB >> 25446676

Knockdown of ventral tegmental area mu-opioid receptors in rats prevents effects of social defeat stress: implications for amphetamine cross-sensitization, social avoidance, weight regulation and expression of brain-derived neurotrophic factor.

Caitlin E Johnston1, Daniel J Herschel, Amy W Lasek, Ronald P Hammer, Ella M Nikulina.   

Abstract

Social defeat stress causes social avoidance and long-lasting cross-sensitization to psychostimulants, both of which are associated with increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area (VTA). Moreover, social stress upregulates VTA mu-opioid receptor (MOR) mRNA. In the VTA, MOR activation inhibits GABA neurons to disinhibit VTA dopamine neurons, thus providing a role for VTA MORs in the regulation of psychostimulant sensitization. The present study determined the effect of lentivirus-mediated MOR knockdown in the VTA on the consequences of intermittent social defeat stress, a salient and profound stressor in humans and rodents. Social stress exposure induced social avoidance and attenuated weight gain in animals with non-manipulated VTA MORs, but both these effects were prevented by VTA MOR knockdown. Rats with non-manipulated VTA MOR expression exhibited cross-sensitization to amphetamine challenge (1.0 mg/kg, i.p.), evidenced by a significant augmentation of locomotion. By contrast, knockdown of VTA MORs prevented stress-induced cross-sensitization without blunting the locomotor-activating effects of amphetamine. At the time point corresponding to amphetamine challenge, immunohistochemical analysis was performed to examine the effect of stress on VTA BDNF expression. Prior stress exposure increased VTA BDNF expression in rats with non-manipulated VTA MOR expression, while VTA MOR knockdown prevented stress-induced expression of VTA BDNF. Taken together, these results suggest that upregulation of VTA MOR is necessary for the behavioral and biochemical changes induced by social defeat stress. Elucidating VTA MOR regulation of stress effects on the mesolimbic system may provide new therapeutic targets for treating stress-induced vulnerability to substance abuse.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25446676      PMCID: PMC4293250          DOI: 10.1016/j.neuropharm.2014.10.010

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  62 in total

1.  Escalated or suppressed cocaine reward, tegmental BDNF, and accumbal dopamine caused by episodic versus continuous social stress in rats.

Authors:  Klaus A Miczek; Ella M Nikulina; Akiko Shimamoto; Herbert E Covington
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

2.  Decreased response to social defeat stress in μ-opioid-receptor knockout mice.

Authors:  Hiroshi Komatsu; Arihisa Ohara; Kazumasu Sasaki; Hiromi Abe; Hisaki Hattori; F Scott Hall; George R Uhl; Ichiro Sora
Journal:  Pharmacol Biochem Behav       Date:  2011-06-15       Impact factor: 3.533

3.  Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice.

Authors:  D S Mathon; H M B Lesscher; M A F M Gerrits; A Kamal; J E Pintar; A G P Schuller; B M Spruijt; J P H Burbach; M P Smidt; J M van Ree; G M J Ramakers
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

4.  Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving.

Authors:  Jeffrey W Grimm; Lin Lu; Teruo Hayashi; Bruce T Hope; Tsung-Ping Su; Yavin Shaham
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

5.  Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats.

Authors:  M A Geyer; P V Russo; D S Segal; R Kuczenski
Journal:  Pharmacol Biochem Behav       Date:  1987-11       Impact factor: 3.533

6.  BDNF overexpression in the ventral tegmental area prolongs social defeat stress-induced cross-sensitization to amphetamine and increases ΔFosB expression in mesocorticolimbic regions of rats.

Authors:  Junshi Wang; Sanya Fanous; Ernest F Terwilliger; Caroline E Bass; Ronald P Hammer; Ella M Nikulina
Journal:  Neuropsychopharmacology       Date:  2013-05-21       Impact factor: 7.853

7.  Changes in Behaviour and Body Weight Following a Single or Double Social Defeat in Rats.

Authors: 
Journal:  Stress       Date:  1996-07       Impact factor: 3.493

8.  Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.

Authors:  Huina Zhang; Mary M Torregrossa; Emily M Jutkiewicz; Yong-Gong Shi; Kenner C Rice; James H Woods; Stanley J Watson; M C Ko
Journal:  Eur J Neurosci       Date:  2006-02       Impact factor: 3.386

9.  Ventral tegmental area opioid mechanisms and modulation of ingestive behavior.

Authors:  A Badiani; P Leone; M B Noel; J Stewart
Journal:  Brain Res       Date:  1995-01-30       Impact factor: 3.252

10.  Alterations in phosphorylated CREB expression in different brain regions following short- and long-term morphine exposure: relationship to food intake.

Authors:  Xiuhai Ren; Kabirullah Lutfy; Michael Mangubat; Monica G Ferrini; Martin L Lee; Yanjun Liu; Theodore C Friedman
Journal:  J Obes       Date:  2013-08-29
View more
  8 in total

Review 1.  Mechanisms for Sex Differences in Energy Homeostasis.

Authors:  Chunmei Wang; Yong Xu
Journal:  J Mol Endocrinol       Date:  2019-02-01       Impact factor: 5.098

2.  Roles of the µ-opioid receptor and its related signaling pathways in the pathogenesis of premenstrual syndrome liver-qi stagnation.

Authors:  Chunhong Song; Ling Xue
Journal:  Exp Ther Med       Date:  2017-04-21       Impact factor: 2.447

3.  Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors.

Authors:  Hildegard A Wulf; Caroline A Browne; Carlos A Zarate; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2022-04-23       Impact factor: 4.530

Review 4.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

5.  A POMC-originated circuit regulates stress-induced hypophagia, depression, and anhedonia.

Authors:  Na Qu; Yanlin He; Chunmei Wang; Pingwen Xu; Yongjie Yang; Xing Cai; Hesong Liu; Kaifan Yu; Zhou Pei; Ilirjana Hyseni; Zheng Sun; Makoto Fukuda; Yi Li; Qing Tian; Yong Xu
Journal:  Mol Psychiatry       Date:  2019-09-05       Impact factor: 15.992

6.  Mice Cohabiting With Familiar Conspecific in Chronic Stress Condition Exhibit Methamphetamine-Induced Locomotor Sensitization and Augmented Consolation Behavior.

Authors:  Paulo Eduardo Carneiro de Oliveira; Isabela Miranda Carmona; Mariana Casarotto; Lara Maria Silveira; Anna Cecília Bezerra Oliveira; Azair Canto-de-Souza
Journal:  Front Behav Neurosci       Date:  2022-04-18       Impact factor: 3.558

7.  Enhanced psychostimulant response, but not social avoidance, depends on GluA1 AMPA receptors in VTA dopamine neurons following intermittent social defeat stress in rats.

Authors:  Megan L Rudolph; Racheal L Neve; Ronald P Hammer; Ella M Nikulina
Journal:  Eur J Neurosci       Date:  2020-07-14       Impact factor: 3.698

8.  Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine.

Authors:  Caroline A Browne; Edgardo Falcon; Shivon A Robinson; Olivier Berton; Irwin Lucki
Journal:  Int J Neuropsychopharmacol       Date:  2018-02-01       Impact factor: 5.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.